Mother of molecules

Lotte Bjerre Knudsen, Scientific Vice President at Novo Nordisk, discovered the molecule liraglutide and oversaw its journey from “underdog candidate” to a treatment for more than a million people with diabetes and obesity.


Tove Iren Spissøy Gerhardsen

By Tove Iren Spissøy Gerhardsen |  Published 11 February 2018


In a podcast to mark International Day of Women and Girls in Science, Lotte reflects on her life inside and outside of the laboratory. How did she balance her career with being a single mum? What is her primary motivation? And how did Game of Thrones help her come to terms with the nickname ‘Mother of Liraglutide’. 


 

Want to read more?


 

Towards a cure for type 1 diabetes

Jacob Sten Petersen is working to cure type-1 diabetes, a disease his five-year-old daughter Vita lives with.

Hear their story

 


The pursuit of oral insulin

Novo Nordisk Chief science officer Mads Krogsgaard Thomsen reflects on the past, present and future of insulin in a tablet.

Oral insulin remains the ‘Holy Grail’ of diabetes

 


Subscribe to Perspectives

Explore features and points of view from Novo Nordisk
and the society we serve.
 



Related to this article
 


Chasing the next breakthroughs

We continuously turn science and technologies into the next generation of efficacious and safe biological medicines. 

Learn about future science at Novo Nordisk